(Q50578517)

English

Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.

scientific article published on 15 March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Christian Beisland

6

object named as

Christian Beisland

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

author name string

Gigja Guðbrandsdottir

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Karin M Hjelle

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Jannicke Frugård

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Leif Bostad

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Hans J Aarstad

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

publication date

15 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Scandinavian journal of urology

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

49

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

388-394

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

The epidemiology of renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Tumor biology and prognostic factors in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

An inside view: VEGF receptor trafficking and signaling

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Vascular endothelial growth factor as a target for anticancer therapy

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Biomarkers in clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Observation should be considered as an alternative in management of renal masses in older and comorbid patients.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

The emerging role of targeted therapy in renal cell carcinoma (RCC): is it time for a neoadjuvant or an adjuvant approach?

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2015.1021833

21 January 2018

Identifiers

10.3109/21681805.2015.1021833

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25773545

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50578517&oldid=969231973"